BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 38524629)

  • 1. A dynamic online nomogram for predicting renal outcomes of idiopathic membranous nephropathy.
    Wang F; Xu J; Wang F; Yang X; Xia Y; Zhou H; Yi N; Jiao C; Su X; Zhang B; Zhou H; Wang Y
    BMC Med Inform Decis Mak; 2024 Jun; 24(1):173. PubMed ID: 38898472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
    Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
    Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of immunotherapy response in idiopathic membranous nephropathy using deep learning-pathological and clinical factors.
    Wei X; Long M; Fan Z; Hou Y; Zhu X; Qu Z; Du Y
    Front Endocrinol (Lausanne); 2024; 15():1328579. PubMed ID: 38524629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning model to estimate probability of remission in patients with idiopathic membranous nephropathy.
    Duo L; Chen L; Zuo Y; Guo J; He M; Zhao H; Kang Y; Tang W
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111126. PubMed ID: 37913570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Machine Learning to Identify Risk Factors and Establishing a Clinical Prediction Model to Predict Atherosclerosis Complications in Idiopathic Membranous Nephropathy.
    Chen Y; He Y; Xing G
    Discov Med; 2023 Aug; 35(177):517-524. PubMed ID: 37553305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic prediction of idiopathic membranous nephropathy using interpretable machine learning.
    Liu Y; Lu Y; Li W; Wang Y; Zhang Z; Yang X; Yang Y; Li R; Zhou X
    Ren Fail; 2023; 45(2):2251597. PubMed ID: 37724550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy.
    Zhang W; Ren Y; Li J
    Ren Fail; 2019 Nov; 41(1):704-717. PubMed ID: 31352863
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy.
    Rojas-Rivera J; Fervenza FC; Ortiz A
    Drugs; 2022 Feb; 82(2):109-132. PubMed ID: 34932208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
    von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
    Rovin BH; Adler SG; Barratt J; Bridoux F; Burdge KA; Chan TM; Cook HT; Fervenza FC; Gibson KL; Glassock RJ; Jayne DRW; Jha V; Liew A; Liu ZH; Mejía-Vilet JM; Nester CM; Radhakrishnan J; Rave EM; Reich HN; Ronco P; Sanders JF; Sethi S; Suzuki Y; Tang SCW; Tesar V; Vivarelli M; Wetzels JFM; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli MA; Cheung M; Earley A; Floege J
    Kidney Int; 2021 Oct; 100(4):753-779. PubMed ID: 34556300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function.
    Brennan E; Kantharidis P; Cooper ME; Godson C
    Nat Rev Nephrol; 2021 Nov; 17(11):725-739. PubMed ID: 34282342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a Deep Learning Model to Quantify Glomerulosclerosis in Kidney Biopsy Specimens.
    Marsh JN; Liu TC; Wilson PC; Swamidass SJ; Gaut JP
    JAMA Netw Open; 2021 Jan; 4(1):e2030939. PubMed ID: 33471115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Learning-Based Segmentation and Quantification in Experimental Kidney Histopathology.
    Bouteldja N; Klinkhammer BM; Bülow RD; Droste P; Otten SW; Freifrau von Stillfried S; Moellmann J; Sheehan SM; Korstanje R; Menzel S; Bankhead P; Mietsch M; Drummer C; Lehrke M; Kramann R; Floege J; Boor P; Merhof D
    J Am Soc Nephrol; 2021 Jan; 32(1):52-68. PubMed ID: 33154175
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.